Skip to content
10-K

Annual Report

THERALINK TECHNOLOGIES, INC.

0001493152-24-001515

← back to feed
Filed
Jan 5, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Jan 4, 2024 6.15B sh
Shares Diluted FY 2023 · Sep 30, 2023 6.15B sh
Shares Diluted FY 2023 · Sep 30, 2022 5.88B sh
Capex FY 2023 · Sep 30, 2023 $163.38K
Capex FY 2023 · Sep 30, 2022 $131.61K
Operating Cash Flow FY 2023 · Sep 30, 2023 −$5.77M
Operating Cash Flow FY 2023 · Sep 30, 2022 −$5.39M
Stockholders Equity FY 2023 · Sep 30, 2023 −$38.12M
Stockholders Equity FY 2023 · Sep 30, 2022 −$6.8M
Stockholders Equity FY 2023 · Sep 30, 2021 −$4.95M
Current Liabilities FY 2023 · Sep 30, 2023 $39.83M
Current Liabilities FY 2023 · Sep 30, 2022 $3.46M
Total Liabilities FY 2023 · Sep 30, 2023 $40.97M
Total Liabilities FY 2023 · Sep 30, 2022 $6.4M
Current Assets FY 2023 · Sep 30, 2023 $1.26M
Current Assets FY 2023 · Sep 30, 2022 $646.98K
Total Assets FY 2023 · Sep 30, 2023 $2.85M
Total Assets FY 2023 · Sep 30, 2022 $2.6M
Eps Diluted FY 2023 · Sep 30, 2023 −$0.01
Eps Diluted FY 2023 · Sep 30, 2022 $0.00
Eps Basic FY 2023 · Sep 30, 2023 −$0.01
Eps Basic FY 2023 · Sep 30, 2022 $0.00
Sga Expense FY 2023 · Sep 30, 2023 $125K
Sga Expense FY 2023 · Sep 30, 2022 $150K
Net Income FY 2023 · Sep 30, 2023 −$30.91M
Net Income FY 2023 · Sep 30, 2022 −$12.74M
Operating Income FY 2023 · Sep 30, 2023 −$8.98M
Operating Income FY 2023 · Sep 30, 2022 −$11.64M
Gross Profit FY 2023 · Sep 30, 2023 $480.56K
Gross Profit FY 2023 · Sep 30, 2022 $343.02K
Cost Of Revenue FY 2023 · Sep 30, 2023 $126.24K
Cost Of Revenue FY 2023 · Sep 30, 2022 $224.89K
Revenue FY 2023 · Sep 30, 2023 $606.8K
Revenue FY 2023 · Sep 30, 2022 $567.91K